North America Virus-like Particles Market
The North America Virus-like Particles Market size was valued at US$ 1,928.37 Mn in 2021 and is projected to reach US$ 3,312.49 Mn by 2028, growing at a CAGR of 8.0% during 2021 - 2028.
Report Coverage
- Product Type: Hepatitis, Cancer/HPV, Gaucher disease
- Source: Yeast, Insect Cell, Plant
- Application: Vaccines and Therapeutics
US$ 1,928.37 Mn
Market size in 2021
US$ 3,312.49 Mn
Market Size by 2028
8.0%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Virus-like Particles Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Virus-like Particles Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Virus-like Particles Market Regional Analysis
6.2 North America Virus-like Particles Market Revenue 2019-2028 (US$ Million)
6.3 North America Virus-like Particles Market Forecast Analysis
7. North America Virus-like Particles Market Analysis – by Product Type
7.1 Hepatitis
- 7.1.1 Overview
- 7.1.2 Hepatitis: North America Virus-like Particles Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Cancer/HPV
- 7.2.1 Overview
- 7.2.2 Cancer/HPV: North America Virus-like Particles Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Gaucher disease
- 7.3.1 Overview
- 7.3.2 Gaucher disease: North America Virus-like Particles Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Virus-like Particles Market Analysis – by Source
8.1 Yeast
- 8.1.1 Overview
- 8.1.2 Yeast: North America Virus-like Particles Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Insect Cell
- 8.2.1 Overview
- 8.2.2 Insect Cell: North America Virus-like Particles Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Plant
- 8.3.1 Overview
- 8.3.2 Plant: North America Virus-like Particles Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Virus-like Particles Market Analysis – by Application
9.1 Vaccines and Therapeutics
- 9.1.1 Overview
- 9.1.2 Vaccines and Therapeutics : North America Virus-like Particles Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. North America Virus-like Particles Market – North America Analysis
10.1 Overview
10.2 North America- 10.2.1 North America Virus-like Particles Market Breakdown, by Key Country, 2022 and 2028 (%)
- 10.2.1.1 North America Virus-like Particles Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 US: North America Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Virus-like Particles Market Breakdown, by Product Type
- 10.2.1.1.2 US: North America Virus-like Particles Market Breakdown, by Source
- 10.2.1.1.3 US: North America Virus-like Particles Market Breakdown, by Application
- 10.2.1.2 Canada: North America Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Virus-like Particles Market Breakdown, by Product Type
- 10.2.1.2.2 Canada: North America Virus-like Particles Market Breakdown, by Source
- 10.2.1.2.3 Canada: North America Virus-like Particles Market Breakdown, by Application
- 10.2.1.3 Mexico : North America Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Virus-like Particles Market Breakdown, by Product Type
- 10.2.1.3.2 Mexico : North America Virus-like Particles Market Breakdown, by Source
- 10.2.1.3.3 Mexico : North America Virus-like Particles Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Merck & Co., Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Pfizer Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Sanofi
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Serum Institute of India Pvt. Ltd.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 BHARAT BIOTECH
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 LG Chem
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 VBI Vaccines Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Dynavax Technologies
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
